ArticleEnvironmental health and preventive medicine2026
BPS and BPF linked to metabolic alterations independent of adiposity in Thai children and adolescents.
Article in Environmental health and preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBisphenol A (BPA) and its structural substitutes, bisphenol S (BPS) and bisphenol F (BPF), are widely used endocrine-disrupting chemicals. While BPA exposure has been linked to metabolic disorders, evidence regarding BPA substitutes in children remains limited, particularly in Southeast Asia.
methodsWe conducted a cross-sectional study among Thai children and adolescents aged 7-18 years classified as normal weight (NW) or overweight/obese (OW/OB). Urinary BPA, BPS, and BPF concentrations were measured using liquid chromatography-tandem mass spectrometry. Anthropometric measurements, body composition, fasting glucose, insulin, lipid profiles, and liver enzymes were assessed. Associations between urinary bisphenol concentrations and metabolic parameters were analyzed using multivariable regression models.
resultsA total of 114 participants were included (26 normal weight and 88 overweight/obese). BPA was detected in all (100%) urine samples, whereas BPS and BPF were detected in 50.0% and 53.6% of participants, respectively. Creatinine-adjusted urinary concentrations of BPA, BPS, and BPF did not differ significantly between NW vs. OW/OB. Higher urinary BPS and BPF concentrations were associated with higher fasting insulin levels (aGMR 1.13; 95%CI 1.05-1.20; p = 0.001) and higher LDL cholesterol levels (aGMR 5.82; 95%CI 0.52-11.11; p = 0.032), respectively. In contrast, higher urinary BPA concentrations were associated with lower fasting insulin levels (aGMR 0.77; 95%CI 0.66-0.90; p = 0.001).
conclusionsExposure to BPA and its substitutes, BPS and BPF, were associated with distinct metabolic alterations independent of weight status. BPS was associated with hyperinsulinemia, while BPF was associated with elevated LDL cholesterol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.